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Two main types of macrophage functions are known: classical (M1), producing nitric oxide,
NO, and M2, in which arginase activity is primarily expressed. Ornithine, the product of
arginase, is a substrate for synthesis of polyamines and collagen, important for growth and
ontogeny of animals. M2 macrophages, expressing high level of mitochondrial arginase,
have been implicated in promoting cell division and deposition of collagen during ontogeny
and wound repair. Arginase expression is the default mode of tissue macrophages, but
can also be amplified by signals, such as IL-4/13 or transforming growth factor-β (TGF-β)
that accelerates wound healing and tissue repair. In worms, the induction of collagen gene
is coupled with induction of immune response genes, both depending on the same TGF-
β-like pathway. This suggests that the main function of M2 “heal” type macrophages is
originally connected with the TGF-β superfamily of proteins, which are involved in regula-
tion of tissue and organ differentiation in embryogenesis. Excretory–secretory products
of metazoan parasites are able to induce M2-type of macrophage responses promoting
wound healing without participation of Th2 cytokines IL-4/IL-13. The expression of arginase
in lower animals can be induced by the presence of parasite antigens and TGF-β signals
leading to collagen synthesis. This also means that the main proteins, which, in primitive
metazoans, are involved in regulation of tissue and organ differentiation in embryogene-
sis are produced by innate immunity. The signaling function of NO is known already from
the sponge stage of animal evolution. The cytotoxic role of NO molecule appeared later,
as documented in immunity of marine mollusks and some insects. This implies that the
M2-wound healing promoting function predates the defensive role of NO, a characteristic
of M1 macrophages. Understanding when and how the M1 and M2 activities came to be
in animals is useful for understanding how macrophage immunity, and immune responses
operate.
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Vertebrate macrophages play an innate defense role against various
pathogens. They perform phagocytosis, bacterial killing, defend
against protozoan and metazoan parasites and take part in wound
healing. To fulfill such protective functions,“resting” macrophages
must be activated. Two main types of macrophage functions have
been identified: classical (M1), producing nitric oxide (NO), and
M2-type, in which arginase (producing the healing molecule,
ornithine) is expressed (1, 2). These responses from macrophages
demand different cascades of biochemical reactions, which are reg-
ulated by specific sets of cytokines. M1 type can be stimulated by
pathogen associated molecular patterns (PAMP) or amplified by
T cell cytokines, such as IFN-γ. In contrast, M2 activity is the res-
ident tissue type, and can be amplified by molecules such as IL-4,
IL-13, and transforming growth factor-β (TGF-β). Local signals
polarize macrophages to an appropriate response. These immune
functions are indispensible for both life of an individual and last-
ing of a species. It is apparent that macrophages, as well as other
cells of innate immune response acting in vertebrates, have their
deep evolutionary roots in cells serving similar function in ances-
tral invertebrates. Various names have been used to define such
cells in different invertebrate groups, i.e., hemocyte, coelomocyte,
amebocyte, or plasmatocyte, collectively named immunocytes (3).
However, regardless of the terminology, they perform the same
immune functions, and are of similar morphology.
Macrophages, the professional phagocytic cells in humans,
derive from circulating monocytes or by self renewal in the tissues,
and acquire new morphological and physiological characteristics
according to the organs and microenvironments, in which they set-
tle. However, this unitarian origin is uncertain for circulating and
tissue phagocytes (immunocytes) in invertebrates (3). Immuno-
cytes and macrophages share ability to be activated by non-self
material and to react through the release a variety of biologically
active molecules such as cytokines, NO, reactive oxygen species,
hydrolytic enzymes, and neuroendocrine mediators. In vertebrate
immunity, various organs and immune cells are involved, while
all the molecules determining invertebrate immune response are
harbored in the immunocytes. From the perspective of this review,
the multifunctional role of invertebrate cells seems instructive in
respect to its inheritance by vertebrates.
In search for selection pressure for macrophage differentia-
tion into M1 and M2 phenotypes, it is tempting to look back
to recognize which of the functions of M2 macrophages is
aligned straight with invertebrate immunocytes and is found pos-
sibly in the most primitive invertebrates. Accumulated evidences
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strongly suggest that a primary function of M2 macrophages is
tissue repair and wound healing (4, 5). This process demands
polyamines and collagen synthesis what strongly depend on
arginase activity (6).
ANIMAL ARGINASES
Arginase (amidinohydrolase, EC 3.5.3.1) is an ubiquitous enzyme
found in bacteria, yeasts, plants, invertebrates, and vertebrates.
Some bacteria possess a related enzyme, agmatinase (Escherichia
coli or Methanobacterium, also Methanococcus), which belong to
Archaebacteria. Agmatinase produce putrescine and urea, arginase
ornithine and urea. Plant arginases are closer to the agmatinase
clade than to the animal one (7, 8). Agmatinases origin predates
that of arginases and the latter would have appeared in the Bac-
teria by recruitment of a wide specificity agmatinase and then its
transfer to an eukaryotic cell (according to Sekowska et al. perhaps
through mitochondria) (8).
Most microorganisms and invertebrates studied to date have
only one type of arginase (9). Arginases from plants and ammo-
niotelic animals are localized in mitochondria (10). In ureotelic
animals, arginase is involved in ammonia detoxication in the
ornithine-urea cycle and is localized in cytosol. The cytosolic
and mitochondrial arginases are isoenzymes named A-I and A-
II, respectively (11). They are encoded by two separate genes.
The arginase gene duplication is relatively recent, and occurred
after separation of vertebrates and invertebrates (9). It has been
suggested that the mitochondrial A-II is a surviving form of the
ancestral arginase, because the cytosolic A-I is restricted to a subset
of more recently evolved species (11).
The pattern of occurrence of the arginase isoenzymes implies
that the primordial function of the enzyme is regulation of cel-
lular arginine and ornithine metabolism, unrelated to the urea
cycle. Ornithine, the product of arginase-catalyzed reaction, is a
substrate for synthesis of proline and polyamines. It is important
to know that ornithine is formed from glutamate via the path-
way leading to arginine synthesis as well. This pathway occurs
in bacteria, plants and animals (10). Both in plants and animals,
polyamines (putrescine, spermidine, and spermine) are involved
in a variety of growth and developmental processes, and they
bind directly to DNA and RNA (12). It has been also shown
that polyamines play a pivotal role in wound healing. Proline (as
hydroxyproline) is indispensable for the collagen biosynthesis in
animals and for the synthesis of cell wall proteins in plants. Partic-
ipation of ornithine in such vital processes suggests that arginase
could be regulated by factors influencing development and growth
of organisms. TGF-β belongs to a superfamily of ancient pro-
teins, known in all bilaterians, members of which play important
signaling roles in embryogenesis (13).
TGF-β SUPERFAMILY OF PROTEINS
Transforming growth factor-β was originally discovered as a
secreted factor that induced malignant transformation in vitro.
It is a prototype member of a superfamily of secreted, homod-
imeric polypeptides. These factors affect a variety of biological
processes in both transformed and normal cells, including regu-
lation of embryogenesis, adult cell differentiation, inflammation,
and wound repair (14, 15).
The TGF-β superfamily may be divided into subfamilies
according to sequence homology. One subfamily consists of the
closely related TGF-β1, -2, and -3. TGF-β2 and -β3 take part in
development signaling, while TGF-β1 signals act in inflamma-
tory responses and tissue necrosis (15). TGF-β1 cDNAs from
different animal species (together with chicken and Xenopus)
show an extremely high degree of conservation (14). Fish TGF-
β homologs cluster with their mammalian TGF-β1, -β2, and -β3
counterparts (15).
Bone morphogenetic proteins were initially characterized as
factors that induce bone and cartilage formation (16, 17). Bone
morphogenetic proteins (BMPs) are critical in development,
hematopoiesis, as well as cellular chemotaxis, and cellular differen-
tiation (18, 19). In the BMPs subfamily, BMPs-2 and -4 bear closest
homology to the decapentaplegic complex protein, a Drosophila
protein mediating dorsal/ventral axis specification (14). BMPs-5,
-6, -7, and -8 most closely resemble Drosophila protein 60A, which
is required for the growth of imaginal tissues and for patterning of
the adult wing (20). Genes encoding members of the bone mor-
phogenetic factor (BMP) protein family have been identified in a
sea anemone and an echinoderm (21).
Genes of TGF-β superfamily members cluster in two major
clades: TGF-β sensu stricto/TGF-β related (e.g., Activins, Leftys,
and GDF8s) ligands and BMP related (e.g., BMPs and Nodals)
(22). TGF-β sensu stricto ligands have been identified only
in deuterostomes (Echinodermata, Hemichordata, and Chor-
data) and are not present in genomic screens of Caenorhabditis,
Drosophila, or Nematostella (23).
Receptors of TGF-β pathway are serine threonine kinases cat-
egorized as type I and type II (24, 25). Vertebrates have seven
distinct type I receptors, each of which can mix and match with
one of five type II receptors to mediate signals for the TGF-β family
ligands (26). Ligand binding to the constitutively phosphorylated
type II receptors stimulates recruitment of type I receptors and
formation of a heterodimeric receptor complex. In the complex,
type I receptors are transphosphorylated by type II receptors (13).
A signal from type I receptor to the nucleus is channeled into one
of two intracellular pathways via Smad family of proteins. Three
of the receptors phosphorylate the R-Smads (receptor-regulated
Smads); Smad2 and Smad3 and thereby transduce TGF-β-like
signals, whereas the other four receptors activate the R-Smads;
Smad1, Smad5, and Smad8 to mediate signals characteristic of
those initiated by BMPs (26–28). These R-Smads form multi-
subunit complexes with a common partner Smads (Co-Smads;
Smad4) before entering the nucleus to affect a response (29). Both
R-Smads and Co-Smads are found in all metazoans (30). I-Smads;
Smad6/7 play inhibitory function, stimulating receptor degrada-
tion, or competing with R-Smads in formation of complexes with
Smad4 (29, 31). The regulatory activity of I-Smads evolved after
divergence of the poriferan lineage (32).
Binding of Smads to DNA is not especially specific; they play
a role of comodulators, which act together with transcription fac-
tors (pan-metazoan Fos/Jun and Myc), transcription coactivators
(pan-metazoan CBP and CBF-β), and transcription corepressors
(Ski/Sno) to recruit basal transcription machinery (32). The for-
mation of Smad complexes gives a wide range of cooperative inter-
actions, thus enables TGF-β signaling to evoke multiple responses
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ranging from embryonic development to wound repair. AR-
Smads (activin/TGF-β-specific R-Smads) transactivate various
target genes through interaction with various DNA-binding part-
ners, including plasminogen activator inhibitor-1 (PAI-1), type I
collagen, junB, Smad7, and Mix.2. For inhibition of cell growth by
TGF-β, AR-Smads induce the transcription of cyclin-dependent
kinase (CDK) inhibitors p21 and p15. In addition, Smad3 binds
directly to the promoter region of c-myc and represses the tran-
scription of c-myc. In contrast, only a few target genes for BMPs
have been identified, including Id (inhibitor of differentiation
or inhibitor of DNA-binding) 1/2/3, Smad6, Vent-2, and Tlx-2.
Id proteins, however, play important roles in multiple biological
activities of BMPs (27). Id proteins act as negative regulators of cell
differentiation and positive regulators of cell proliferation (33).
Ligands, receptors of the TGF-βpathway, and Smads are ancient
proteins. They emerged already in the metazoan stem lineage. I-
Smads, multiple ligand traps, and SARA have been added to the
signaling pathway after the divergence of sponges (32).
Transforming growth factor-β and BMP signaling pathway is
evolutionary conserved, as it was shown for worms, flies, and
vertebrates [Ref. (26)].
TGF-β FUNCTION IN EMBRYOGENESIS ANDWOUND
HEALING OF INVERTEBRATES
Caenorhabditis elegans is a free-living nematode, a member of the
lineage, which appeared more than 470 million years ago (34).
There are at least three distinct TGF-β-like pathways in this worm
(35). One of them controls the body size and morphology of the
male tail, but five genes of this pathway (dbl-1, sma-2/-3/-4/-6)
contribute to resistance against Pseudomonas aeruginosa infection
(36). This pathway controls induction of some genes induced after
Serratia marcescens infection, including lys-8 (lysozyme) (37).
Moreover, dpp, a dbl-1 homolog in Drosophila, is up-regulated
upon immune challenge (38, 39). This pathway shows a clear
homology to the mammalian TGF-β pathway (40), which plays
an important role in immune responses (41). Some targets of this
pathway in Caenorhabditis are known: mab-21, involved in male
ray pattern formation, and lon-1 and lon-3, involved in regulation
of the body size. The latter two encode a cysteine-rich secretory
protein and collagen, respectively. The lon-1 and lon-3 are mainly
expressed in the hypodermis, as they are essential for the body size
regulation (42, 43).
This finding implies that the ancestral pathway of TGF-β sig-
naling in embryogenesis is bound with immune reactions in the
Protostomia, suggesting that TGF-βpathway in immunity has been
conserved generally across their evolution. Induction of collagen
gene in Caenorhabditis during bacterial infection links develop-
mental processes with the tissue repair induced by pathogens.
Collagen is needed for extracellular matrix deposition during both
embryogenesis and wound repair. Hemocytes must migrate to
wounded area for the synthesis of collagen fibrilles. In lesioned
leeches (Annelida), immunocytes are the first cells that are also
involved in closing the wound by using pseudopodia to bridge
the epithelial edges. Subsequently, additional immunocytes com-
plete the obstruction together with granulocytes and NK-like
cells (3). Throughout embryogenesis, hemocytes carry out impor-
tant developmental functions within the embryo, such as the
engulfment and removal apoptic cells and the laying down of many
extracellular matrix molecules, including collagen IV and laminin,
which compose the basement membrane surrounding internal
organs [Ref. (44)]. Drosophila hemocytes are similar to leukocytes
in respect of activation and migration toward wounds. A require-
ment for phosphoinositide 3-kinase (PI3K) for the polarization
and active hemotaxis of hemocytes toward an epithelial wound
shows a striking analogy with the mechanism of cell chemo-
taxis used by Dictyostelium discoideum, mammalian neutrophils
(45), as well as fish macrophages (46). Migration of Drosophila
hemocytes toward wounds depends on CDC42 and Rho signal
transmission (47) and PI3K signaling (45). The migratory pattern
of hemocytes in Drosophila embryos is independent of PI3K sig-
naling, but depends on chemotactic signals from the PDGF/VEGF
ligands (45).
During wound healing in the snails Lymnaea stagnalis (48) and
Limax maximus (49), hemocytes exhibit fibroblast activity while
secreting the extracellular matrix. Similar transformation of a cell
type was observed in fibroblasts transformed into myofibroblasts
at injured sites when acting in wound contraction (50). It points
to the role of hemocytes in invertebrate tissue repair, similarly
to the mammalian wound models, in which the macrophages are
essential cells participating in wound healing (51). PDGF-AB (het-
rodimer) and TGF-β1 stimulate chemotaxis of different cell types,
especially hemocytes (49). The increased number of hemocytes
contribute to earlier wound closure at the injured site. The removal
of damaged tissue residues is also accelerated by stimulation of
the phagocytic activity of recruited hemocytes. TGF-β1 regulates
expression of genes of collagen type I and III, and fibronectin
(52, 53). This may mean that the mechanism of wound healing is
conserved from invertebrates to mammals what’s more, arginase
gene expression has been documented in hemocytes (54).
Tissue injury in humans triggers migration of macrophages,
platelets, fibroblasts, myofibroblasts, and eosinophils releasing
TGF-β. TGF-β stimulates fibroblasts and other reparative cells
to proliferate and synthesize extracellular matrix components
(elastin fibers, collagen fibrils, protein–polysaccharides, and gly-
coproteins). This leads to a provisional repair, followed by fibrosis
and ultimately scarring. Fibrosis of many organs (liver, heart, kid-
ney, pancreas, and skin) is mediated by TGF-β [Ref. (55)]. In exper-
imental murine Schistosoma mansoni infection, gene expression
of type I and type III interstitial collagens, basement membrane
collagen, and TGF-β1 show increased levels of expression after
primary infection (56). Transcription of type I procollagen chains
proα1 and proα2 is TGF-β-regulated through two different path-
ways during tissue fibrosis. Expression of proα1 depends on the
TGF-β activator protein and expression of proα2 depends on Smad
signaling of TGF-β pathway. In addition, there are other cellular
factors and DNA-binding elements required for the transcription
of these type I procollagen genes. New synthesized procollagen
molecules are processed by enzymes outside the cell.
In the evolution of nematodes, they changed their original free-
living habitus to commensal one and finally to parasitize tissues of
animals (57). The evolution of plathelminths was different. They
changed ectoparasitic mode of life of monogenean trematodes to
endoparasitic one of digeneans and tapeworms. Invertebrates that
are parasitized by these worms, heal damages to the tissue due
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to activation of polyamine and collagen synthesis. Thus arginase
induction required for wound healing in animals without acquired
immunity could be based on the TGF-β signaling pathway.
Aside being a substrate for proline synthesis pathway, ornithine
is a substrate for polyamine production in all eukaryotic cells. As
polyamines are required for high rates of protein synthesis and
cell proliferation (58), they play a pivotal role in repair processes.
Stimulation of putrescine synthesis was observed during regen-
eration of earthworms and planarians (59). Regenerating tissues
produce spermine, and injured or dying cells release spermine
into the extracellular milieu, so that tissue levels of this compound
increase significantly at inflammatory sites of infection or injury
(60). In snails resistant to the Schistosoma mansoni infection (61),
increased gene expression of ornithine decarboxylase in hemocytes
points to the enhancement of arginase activity, which results in
ornithine production (62, 63). Ornithine decarboxylase produces
putrescine used for the synthesis of other polyamines involved
in DNA protection during cell proliferation. Polyamines assist in
wound healing following miracidial penetration.
Mollusks can be infected with viruses, bacteria, fungi, protists,
digenean trematodes, polychetes, and copepods (64). The infective
stage of the protozoan (haplosporidian) Haplosporidium nelsoni
invades the bivalve tissues through gills and palps spreading then
through the body. Infection of the bivalve Crassostrea virginica
with this protist leads to an increase in the number of circulating
hemocytes and their infiltration into tissues (65). It is suggested
that these cells are involved in limiting parasite damage by plugging
lesions, removing debris, and repairing damaged tissue.
In hemocytes of the snail Biophalaria glabrata infected with the
digenean trematode Schistosoma mansoni, for which a definitive
host is human, the expression of TGF-β receptor gene was slightly
lowered in comparison with those of resistant strains. Early gene
expression was measured only 2 h post exposure to miracidia (61).
Transforming growth factor-β signaling is essential for extra-
cellular matrix development in cold-blooded animals (66). As a
result of infection of salmonid fish with the ectoparasitic caligid
crustacean Lepeophtheirus salmonis insufficient expression of sev-
eral regulatory proteins, among them TGF-β, brought up delayed
expression of collagen 2a and delayed wound healing. Arginase
gene expression was markedly increased in intact skin of infected
fish (67). Support for the hypothesis that arginase expression
is related to collagen expression comes from observations that
arginase trancripts are down-regulated in concert with collagen
a in resistant oysters five days after challenge with the gram-
negative bacterium Roseovarius crassostreae (68). This extracellular
pathogen colonizes the oyster’s inner shell surface and causes
lesions in the epithelial mantle.
Efficient wound healing in invertebrates based on induction
of genes for arginase and collagen biosynthesis (68) mediated by
TGFβ (49, 65), but without cytokines of Th2 cluster being involved,
may mean that also in vertebrates such mechanism of healing is
possible. An innate response to injury may occur in absence of
any adaptive response and can be triggered solely by tissue injury
(69). Although IL-4/IL-13 mediated responses may be important
in tissue repair, they do not appear to be essential, as the incision
is effectively healed in the mice that lack IL-4 or IL-4 receptor.
Nonetheless, the importance of type 2 cytokines in damage tissue
remodeling and fibrosis is well documented (70). Possibly IL-4
and/or IL-13 mediate a more rapid form of tissue repair that it
is necessary just to maintain tissue integrity. According to Allen
and Wynn (71), Th2 immunity in vertebrates evolved as a means
to rapid tissue damage repair caused by metazoan invaders rather
than just to control parasite numbers.
M2-TYPE OF MACROPHAGE RESPONSE WITHOUT HELP OF
Th2 CYTOKINES
Transforming growth factor-β, IL-4, and IL-13 are key cytokines
skewing macrophages to the M2-type response that is typical for
allergy and metazoan parasite infection. Arginase induction is
the hallmark of this response. This raises the question whether
M2-type of macrophage response could be induced solely by
multicellular parasites without help of Th2 cytokines.
A strong wound healing response would occur in helminth
infection, as tissue migratory or tissue invasive parasites often
lead to physical trauma. A Th2-type protective immune response
develops following infection with many tissue-dwelling intestinal
nematode parasites (Heligmosomoides polygyrus, Trichuris muris,
or Trichinella spiralis) or trematodes and is characterized by ele-
vations in IL-4 and IL-13 and increased numbers of CD4+ T cells,
granulocytes, and macrophages. These cells accumulate at the site
of infection and may mediate resistance to worms (72, 73). This
is a kind of defense strategy of the host, but it eventually favors a
survival of parasite.
Excretory-secretory (ES) products or parasite enzymes acti-
vate and regulate host-immune response at the macrophage level
through inhibition of pro-inflammatory cytokines production
and induction of macrophages toward the M2-type of activation.
Trichinella spiralis is the parasitic nematode of higher verte-
brates, which causes pathological changes in various tissues of the
host. Binding of TGF-βwith specific antibodies abrogated effect of
infection on arginase activity in guinea pig alveolar macrophages
(74). ES products from Trichinella spiralis raise the expression of
interleukin-10, TGF-β, and arginase-1 in J774 A.1 macrophages
in the absence of Th2 cytokines (75). In addition, ES products
significantly inhibit translocation of NF-κB into the nucleus and
the phosphorylation of both ERK1/2- and p38MAP-kinases in
J774A.1 macrophages stimulated with lipopolysaccharide (LPS)
(an antigen of Gram-negative bacteria). Treatment of peritoneal
macrophages with a recombinant of 53-kDa protein derived from
T. spiralis brought about expression of mannose receptor, a novel
mammalian lectin (Ym1), arginase-1, and IL-10, hallmarks of M2
phenotype. This effect was independent of IL-4Rα, but dependent
on STAT6 (76).
Infections with the trematodes Fasciola hepatica or Schistosoma
mansoni cause destruction of the host liver tissues, damage to bile
ducts, atrophy of the portal vessels, and secondary pathological
conditions. Secreted peroxiredoxins may induce alternative acti-
vation of macrophages. They stimulate Ym1 expression in vitro,
which shows their action independent of IL-4/IL-13 signaling (77).
As expected, administration of recombinat peroxiredoxins from
these trematodes to the wild type and IL-4−/− and IL-13−/−mice
induces alternatively activated macrophages. Also eggs of S. man-
soni laid in the smallest blood vessels cause tissue reaction in the
form of inflammation, necrosis, connective tissue encapsulation,
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and eventual scar formation during their migration through the
tissue to the colon. The eggs trapped in the liver induce fibrosis and
are associated with production of proline (78). The immunomod-
ulatory pentasaccharide LNFPIII, which contains the Lewis X
trisaccharide, is a component of schistosome soluble egg anti-
gen. It up-regulates expression and activity of arginase-1, as well
as expression of Ym1 in macrophages (79) but does not induce
expression of FIZZ-1, MGL-1, or MMR. Upregulation of arginase
I and Ym1 is independent of IL-4 and IL-13. Binding of LNFPIII
to C-type lectins on the surface of macrophages leads to alter-
native nuclear factor (NF)-κB activation (80) and may induce
arginase-1 and Ym1 directly without IL-4 and IL-13. An injec-
tion of LNFPIII initiates alternative activation, do not mimicking
complete infection because it does not cause FIZZ-1 expression,
besides upregulation of Ym1. Interestingly, Loke et al. (69) have
found that surgical trauma leads to elevation of markers of alter-
native activation without presence of T cells. However, the innate
expression of Ym1, FIZZ-1, and arginase-1 requires either IL-4
or IL-13. Expression of arginase-1 occurred early in response to
surgery. It increases with growing up to third day post surgery and
then returns to baseline by 1 week, but is sustained only in the
parasite-implanted animals.
Protozoan parasite Toxoplasma type I and type III strains may
induce the M2 phenotype, while the type II strain induces M1
phenotype (81). The alternative activation of macrophages is
dependent in large part on the Toxoplasma polymorphic protein
kinase ROP16, while the classical activation of macrophages by
the type II strain is due to unique ability of its GRA15 protein
to activate NF-κB pathway and elicit pro-inflammatory cytokines.
Both enzymes seem act in a way specific to the host. According
to authors, parasite effectors from different Toxoplasma strains
evolved to work optimally in hosts predisposed to certain types
of immune responses, such as those along the Th1/Th2/Th17 or
M1/M2 axes. Ending up to the wrong host might lead to severe
disease and failure to establish chronic infection.
MACROPHAGE POLARIZATION BY TGF-β SUPERFAMILY
PROTEINS
In the adult Drosophila immune response, Dpp (decapentaplegic),
a BMP-type signal, is rapidly activated by wounds and represses
the production of antimicrobial peptides. The activin/TGF-β-like
signal dawdle (daw), in contrast, is activated by Gram-positive
bacterial infection but repressed by Gram-negative infection or
wounding; its role is to limit infection-induced melanization.
Genes dpp and daw are expressed in hemocytes but also in other
tissues. The hemocyte population in the adult fly is comprised of
subsets of cell that can be defined through distinct gene expression
profile. According to Clark et al. (82), it is likely that expression of
dpp and daw by a subset or subsets of phagocytes indicates distinct
immunomodulatory functions by these cells. Both dpp and daw
inhibit immune responses. This makes the fly similar to mam-
mals, in which both activin and TGF-β-like and BMP-like signals
are largely anti-inflammatory (83, 84), in contrast with the nema-
tode Caenorhabditis, where the TGF-β superfamily member dbl-1
analog of dpp promotes a variety of antimicrobial responses (85).
Both anti- and pro-inflammatory response due to activa-
tion of TGF-β superfamily receptors by their ligands, TGF-β,
bone morphogenetic protein-7 (BMP-7), BMP-6 have been found
in macrophages of rodents. Surprisingly few studies have eval-
uated the effect of TGF-β signaling on macrophages. Mouse
macrophages lacking TβRII (transforming growth factor-β recep-
tor II) are defective in expression of genes that characterize the
M2-type of activation, suggesting that TGF-β signaling is needed
for the alternative activation of macrophages. Lack of TβRII−/−
is associated with basal expression of arginase-1 (protein and
mRNA) significantly decreased in comparison with the wild type
both in naïve peritoneal macrophages and bone marrow-derived
macrophages, BMDM, (86). Moreover, when TβRII−/− BMD
macrophages are polarized toward an M2 phenotype with IL-4,
induction of Arg-1 is very low. Expression of Arg-1 is increased
in WT macrophages stimulated with TGF-β1. As transcription of
other M2 markers including ym1 ceases in TβRII−/− BMDMs,
apparently signals through TβRII modulate the M2 transcription
program. TGF-β contributes to M2 polarization of macrophages
with IL-4 through co-signaling to Akt, which is one of the TGF-β1
non-Smad-associated signal transduction pathways in other cell
types (87).
Bone morphogenetic protein-7 activates receptor BMPR2
in monocytes, which results in phosphorylation of R-
SMAD1/5/8/and activation of down-stream mediators in the
Smad pathway. It plays a role in polarization also in M2
macrophages, as manifested by increased expression of anti-
inflammatory cytokines (88). In bone marrow-derived M2
macrophages, increased polarization results from activation of
PI3K pathway (89). Activation of the PI3K pathway controls pro-
duction of transcription factors. They regulate key inflammatory
cytokines resulting in increased expression of anti-inflammatory
markers (90). Arginase-1 and IL-10 level is significantly increased
following treatment of monocytes with BMP-7 (88). In addition
to the canonical Smad-dependent pathway for TGF-β signaling,
a Smad-independent pathway, namely the mitogen-activated pro-
tein kinase (MAPK) pathway (p38MAPK and JNK) may act (91).
Activation of the NF-κB pathway via the X-linked inhibitor of
apoptosis (XIAP) transduces BMP signaling (92). Different to
BMP-7, BMP-6 may induce pro-inflammatory inducible NOS
(iNOS) and TNF-α in peritoneal macrophages (93). The general
phenotype of macrophages in response to BMP-6 is similar to
that of macrophages exposed to LPS (94). BMP-6 in macrophages
appears to counteract TGF-β. It is likely that the BMP-6 induc-
tion of expression of inducible NO synthase occurs through IL-1β
via Smad and NF-kappaB signaling pathways (95). IL-1β, in turn,
up-regulates iNOS expression via the NF-κB pathway. However,
the possibility that BMP-6 may directly activate NF-κB signaling
could not be excluded because TGF-β activates kinase 1 (TAK1),
which is a component of the BMP signaling pathway in Xeno-
pus and mouse embryonic development (96, 97). TAK1 and its
regulators (TAB1 and TAB2) form complexes and activate the
IKK complex (98). The latter possibility suggest that pathway
used in embryonic signaling could be used in innate immu-
nity response to induce NO production. Interestingly, NO and
ornithine (the product of arginase described earlier), both origi-
nate from the same amino acid, arginine, via different enzymatic
reactions, which were called figuratively “The arginine fork in the
road” (99).
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EVOLUTION OF NITRIC OXIDE SYNTHASE
In macrophages, NO is a crucial mediator of cytotoxicity. It has
been shown to have microbicidal, antiviral, antiparasitic, and
antitumor effects. NO production is usually mediated by nitric
oxide synthase (NOS) (EC 1.14.13.39). To date, three isoforms
of NOS have been characterized: iNOS, neuronal NOS (nNOS),
and endothelial NOS (eNOS). In macrophages, iNOS is transcrip-
tionally induced in response to LPS, TNF-α, interferon-γ (IFN-γ),
and interleukin-1β (IL-1β) (100). The signaling pathway for iNOS
expression in macrophages involves NF-κB and signal transducer
and activator of transcription (STAT).
Three NOS isoforms originally described in mammalian tis-
sues (100, 101) are encoded by distinct genes: for eNOS, nNOS,
and iNOS. All they share much of their sequence with cytochrome
P450 reductase in their C-terminal reductase domains and have a
common oxygenase domain.
The interdomain linker between the oxygenase and reduc-
tase domains contains a calmodulin-binding sequence. In eNOS
and nNOS, physiological concentrations of Ca+2 in cells regulate
the binding of calmodulin to the linker, thereby initiating elec-
tron transfer from the flavins to the heme moieties. In contrast,
calmodulin remains tightly bound to the iNOS (Ca+2 -insensitive
isoform). Expression of iNOS is strongly activated in the presence
of LPSs or in response to potentially damaging stimuli, resulting
in a high and long-term NO yield. iNOS is primarily involved in
defense reactions and cytotoxicity.
Nitric oxide synthase ancestry goes back to early bacteria from
before a couple billion years ago. In all prokaryotic enzymes only
the oxygenase domain is found (102, 103). In NOS evolution,
multiple events of gene loss and gain in various lineages occurred.
Nitric oxide synthase occurs probably in almost all invertebrates
ranging from jellyfish (104) and hydra (105) to fly (106) and para-
sitic worms (107), as well as mollusks and arthropods (108). NOS
enzymes from insects (109–111) and mollusks [(112), Ref. (113)]
have greater overall sequence similarity to a neuronal-like NOS
than to iNOS or eNOS in vertebrates. However, cnidarian (Dis-
cosoma) and slime mold (Physarum) NOSs (113, 114) lack the
distinct structural element that is present as an insertion in the
reductase domains of constitutive NOSs but is absent in iNOSs
of vertebrates. This insert is thought to be an autoinhibitory loop,
which impedes binding of Ca2+ to calmodulin and enzymatic acti-
vation. This insert reduces potentially toxic NO yields following
the activation of iNOS. Since the Discosoma NOS is structurally
similar both to the only known non-animal conventional NOS
and to vertebrate iNOS isoforms, the inducible type of the enzyme
may be ancestral for animal NOSs. In contrast to vertebrate species,
which have three NOS genes, only one type of NOS isoform has
been found in the genomes from insects and tunicates. Mollusks,
sea urchins, and cephalochordates have at least two NOS genes
but no NOS genes have been identified in Caenorhabditis ele-
gans. These findings imply that more than one NOS co-existed
in the common ancestor of all animals and it was lost in some
animal lineages in the course of evolution. On the other hand, in
some groups, such as mollusks (with at least two different types of
NOS) and chordates (2–3 NOS genes), duplication events for NOS
genes may have occurred more than once. Moreover, duplications
happened independently in the evolution of inducible type NOS,
since some fishes have more than one iNOS-like gene (113). The
diversification of vertebrate NOSs occurred in parallel in many
lineages, which cluster into three distinct groups corresponding
to the mammalian iNOS, eNOS, and nNOS, iNOS probably being
most basal. eNOS apparently originated as the last, within the
mammalian clade.
The primary and evolutionary conservative role of NO is
NO-cGMP signaling, acting in many different invertebrates from
sponges, insects, and mollusks to cephalopods [Ref. (115)]. A
defense function of NO was observed in the crustacean (116),
and mollusk hemocytes [Ref. (117)]. In general, defense func-
tions in invertebrates are accomplished by superoxide produced
by phagocyte NADPH oxidase (which appeared before the diver-
gence of the Choanoflagellata and metazoans), antimicrobial pep-
tides, lysozymes, hemolymph clotting, and melanization [Ref.
(115)]. This suggests that the function of arginase as the key
enzyme producing ornithine in metazoans, indispensible for tis-
sue repair, is more ancient than the cytotoxic activity of free
radical NO, the product of NOS. One may conclude that the
wound healing function of M2 macrophages is more deeply
rooted in history of life than the cytotoxic activity of M1
macrophages.
REGULATION OF NITRIC OXIDE PRODUCTION IN INSECTS
AND MICE
Most of research on the NOS refers to three animal species: fruit
flies Drosophila melanogaster, mice Mus musculus, and humans
Homo sapiens. Presumably, the insects are the least advanced its
evolution. Mice, as rodents, are relatively primitive mammals,
closest relatives of the order Primates, to which humans belong.
From evolutionary point of view, the rodent macrophages, com-
monly used as a model for immunological investigations, better
suit to studies on innate immunity reactions in vertebrates than
human ones.
The model for studying arthropod immunity is the antimi-
crobial defense in Drosophila. IMD pathway performs a signaling
function by inducing host defenses in response to Gram-negative
bacteria. Activation the IMD signaling pathway leads to the acti-
vation of NF-κB homolog Relish and production of antimicrobial
peptides (118, 119). The cells in Drosophila gut detect the pathogen
and activate hemocytes via an NO-dependent signal. The hemo-
cytes act in turn to activate immune-inducible gene expression in
the fat body (the insect liver analog) by an as-yet-unknown signal
(118). In Anopheles stephensi, expression of immune responsive
genes, including NOS, is up-regulated in response to the presence
of Plasmodium parasites in the midgut (120).
It has been found that A. stephensi NOS possesses a puta-
tive LPS- and cytokine-responsive transcription factor binding
site (121). Invertebrates have cytokine-like proteins similar to
the interleukins and tumor necrosis factors of vertebrates (122).
Transcription factor binding sites in the 5′-flanking sequence
demonstrate a bipartite distribution of LPS- and inflammatory
cytokine-responsive elements that are strikingly similar to that
described for murine iNOS gene promoters (123, 124). Studies
of Drosophila NOS regulation have shown (125) that insect NOS
activity is solely dependent on Ca2+ and calmodulin, like the con-
stitutive vertebrate NOSs. Although the activity of Drosophila NOS
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is very low compared to other NOSs, low amount of NO produced
may be sufficient for functioning as a signaling molecule (126).
As already commented, NO is rather a signaling than cytotoxic
molecule in invertebrates. In vertebrates, as exemplified by rodent
macrophages, high amounts of NO are produced as a result of
activation of iNOS with LPS and IFNγ. This is a part of defense
armor, which otherwise acts as a double edge sword. However,
stimulation of macrophages only with LPS results in a low NO
production and less than 15% of cells is iNOS positive. IFNγ
enhanced LPS-induced secretion of NO by recruiting increasingly
greater numbers of macrophages into the production of iNOS
(127). The gene of iNOS is synergistically activated by LPS and
IFNγ (123, 124). The iNOS promotor contains two important
regions termed RI and RII. The effects of LPS stimulation are
mediated by elements in both RI and RII, whereas IFNγ functions
through RII only (123, 124). In addition, IFNγ alone is not able
to activate through RII, acting solely to augment the effect of LPS
on RI (123). A variety of LPS response elements, including NF-κB,
occurs and the NF-κB site in LPS-mediated transcriptional activa-
tion of iNOS is required (128). Perhaps the increase of frequency
of LPS responsive cells in effect of IFNγ action, and consequent
NO production is the key factor to enhance NO formation. It leads
to M1 type of response.
TGF-β1 seems to be the most potent regulator of iNOS. In
natural killer cells, neutrophils and macrophages, TGF-β1 dimin-
ishes iNOS activity, influencing gene expression, mRNA stability
and translation, and NOS protein stability (129). For suppres-
sion of LPS-stimulated iNOS in bone marrow-derived mouse
macrophages, both Smad2 and Smad3 are required. Down regu-
lation of iNOS mRNA undergoes by suppressing the IRF3- IFNβ-
STAT1 pathway (130). Mutual feedback regulation between iNOS
and TGF-β1 is also possible, as latent TGF-β1 can be activated by
exogenous NO (131).TGF-β appears to be important endogenous
mediator that keeps resident/wound healing macrophages in M2
dominant mode. A decrease in TGF-β production in macrophages
brought about “activation” of these cells. Similarly, removing of
TGF-β from cell culture (coming from serum added), caused much
more NO produced, and less synergy between LPS and IFN-γ in
stimulation of NO production (1).
CONCLUDING REMARKS
Sophisticated ways of signaling observed in contemporary ver-
tebrates show how complex are results of molecular evolution.
Although specialization of macrophage responses is based on
two ancient mechanisms: cytotoxic activity of iNOS and ana-
bolic function of arginase (Figure 1). It is suggested here that
not defense against infection but rather the TGF-β-signaling was
at the origin of the M1/M2 macrophage specialized functions.
Such signaling is known to operate already in primitive inverte-
brates, both in their embryonic development and wound healing.
A prototypic inducer of M1 response bacterial LPS, alone acti-
vates production of only a small amount of NO by iNOS-type
enzyme and generates signal propagation through cGMP cyclase
in invertebrates. It remains unknown, to what degree inverte-
brate analogs of IFNγ would be able to enhance LPS-induced
NO production, as no experimental data about enhancement of
NO production by IFNγ-like cytokine in Drosophila are avail-
able. Presumably, the ability of M1 macrophages to produce large
amounts of NO in response to microbial infection is a verte-
brate evolutionary invention, known to be present already at
the fish grade (132). At this stage the arginase function in M2
macrophages, inherited after invertebrate ancestors, was to deliver
ornithine for processes of extracellular matrix synthesis, of impor-
tance in organogenesis and wound healing. The latter serves also
as a protection against metazoan parasites. Thus, the main func-
tion of M2 macrophages is originally connected with the TGF-β
FIGURE 1 | Proposed order of appearance of arginase,TGF-β superfamily of proteins, and nitric oxide synthase (NOS), superimposed on the metazoan
phylogenetic tree, implies a pattern of polarization of vertebrate macrophage to M1 and M2-types of activation.
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superfamily of proteins, which in primitive metazoans are involved
in regulation of tissue and organ differentiation in embryogenesis.
Looking back in evolution also indicates that both NOS/NO and
arginases/ornithine are primitive innate responses in macrophages
that long preceded the development of T and B cells (adaptive
immunity).
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